カテゴリ： GlobalData, アメリカ, 企業調査

Case Western Reserve University-製薬・医療分野：企業M&A・提携分析

◆英語タイトル：Case Western Reserve University - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード：DATA8011922
◆発行会社（調査会社）：GlobalData
◆発行日：2017年12月13日
◆ページ数：62
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：製薬・医療
◆販売価格オプション（消費税別）
Single UserUSD250 ⇒換算￥37,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD500 ⇒換算￥74,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
Case Western Reserve University (CWRU) is a private research university that offers educational and research programs. The institute provides bachelor, master’s, doctoral and research programs through its colleges and professional schools, besides postdoctoral training. It offers courses in various fields such as engineering, arts and sciences; dentistry, management, law, medicine, nursing and social work. CWRU provides research facilities to its students from various fields. The institute offers services such as IT services, library and student information system. It also offers technology transfer services. CWRU is headquartered in Cleveland, Ohio, the US.

Case Western Reserve University – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Case Western Reserve University, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Case Western Reserve University, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Case Western Reserve University, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Case Western Reserve University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Case Western Reserve University, Medical Devices Deals, 2011 to YTD 2017 10
Case Western Reserve University, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Case Western Reserve University, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
Red5 Pharma Enters into Licensing Agreement with Case Western Reserve University 12
Xbiotech Enters into Research Agreement with Case Western Reserve University School of Medicine 13
ImageIQ Enters Into Co-Development Agreement With NCRM, CCBC And Cleveland Clinic 14
Licensing Agreements 15
ReXceptor Enters into Licensing Agreement with Case Western Reserve University 15
Vision Medicines Enters into Licensing Agreement with Case Western Reserve University 16
Sujana Biotech Enters into Licensing Agreement with Case Western Reserve University 17
Tracon Pharma Expands Licensing Agreement with Case Western Reserve University 18
NeoProteomics Exercises Option For Licensing Agreement With Case Western Reserve University For Software To Advance Medical Treatments 19
Case Western Reserve University – Key Competitors 20
Case Western Reserve University – Key Employees 21
Case Western Reserve University – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 24
Legal and Regulatory 24
Mar 28, 2016: CWRU awarded full AAHRPP accreditation for Human Research Protection Program 24
Government and Public Interest 25
Nov 14, 2017: Shining a light on the nervous system to thwart disease 25
Nov 10, 2017: New Study Offers Added Hope for Patients Awaiting Corneal Transplants 26
Oct 04, 2017: Antifungals and Probiotics May Play a Key Role in the Development of Treatment for Crohn’s Disease 27
Aug 25, 2017: CWRU Awarded Funding to Understand How A Virus-Like Particle from Plants Stimulates Potent Anti-Tumor Response 28
Aug 01, 2017: Case Western Reserve University: Missing Signals Leads to Diabetic Nerve Injury 30
Jul 05, 2017: New Brain Cancer Drug Targets Revealed 31
Jun 29, 2017: CWRU Researcher Awarded Over $4.7 Million to Develop Drug-Delivery Nanotechnology 32
May 31, 2017: Case Western Reserve University Receives $6 Million to Study Barrett’s Esophagus 33
May 17, 2017: Early MRI May Lower Costs for Prostate Cancer Treatment 34
Oct 17, 2016: FDA awards 21 grants to stimulate product development for rare diseases 35
Sep 20, 2016: Computerized analysis of tissue slide images reveals underlying genomics of ER+ breast cancer 37
Sep 08, 2016: New electrical stimulation therapy may improve hand function after stroke 38
Sep 06, 2016: CWRU researchers receive NIH grant renewal to build on progress in understanding Crohn’s disease 39
Aug 08, 2016: Researchers lead team in discovering possible approach to slow growth of certain colon cancers 40
Jun 28, 2016: Researcher receives grant to understand why some HIV+ individuals avoid ‘duet of death’ 41
Jun 08, 2016: Drug candidate shrinks tumor when delivered by plant virus nanoparticle 42
May 26, 2016: Researchers findings offer promise for the development of new treatments for chronic pain and cancer 44
May 24, 2016: Researchers discover moving, electrically “silent” source initiates brain waves 45
May 04, 2016: Case Western Reserve University researchers land federal grants 47
Apr 26, 2016: First small molecule targeted therapy to mitigate hearing loss in Usher syndrome type 3 49
Feb 18, 2016: New image analytics may offer quick guidance for breast cancer treatment 50
Jan 20, 2016: Age-related response to the hepatitis B vaccine linked to inflammation 52
Jan 15, 2016: Plasma marker of vascular disease confirmed in type 1 diabetes patients 53
Jan 05, 2016: Powerful protein promotes post-injury regeneration and growth of injured peripheral nerves 54
Product News 56
Jul 19, 2017: Novel Screening Method Reveals Glioblastoma Drug Target 56
Jun 28, 2016: Shape-Changing Enzyme Suggests How Small Doses of Anti-HIV Drug Might Treat Alzheimer’s Disease 57
Feb 10, 2016: MS Trial Alert: People with MS Being Recruited for Study of Teleconference Intervention to Increase Exercise and Decrease Fatigue 59
Feb 02, 2016: CWRU researcher developing portable method to detect tainted medicines and supplements 60
Appendix 62
Methodology 62
About GlobalData 62
Contact Us 62
Disclaimer 62

List of Tables
Case Western Reserve University, Pharmaceuticals & Healthcare, Key Facts 2
Case Western Reserve University, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Case Western Reserve University, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Case Western Reserve University, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Case Western Reserve University, Deals By Therapy Area, 2011 to YTD 2017 9
Case Western Reserve University, Medical Devices Deals, 2011 to YTD 2017 10
Case Western Reserve University, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Red5 Pharma Enters into Licensing Agreement with Case Western Reserve University 12
Xbiotech Enters into Research Agreement with Case Western Reserve University School of Medicine 13
ImageIQ Enters Into Co-Development Agreement With NCRM, CCBC And Cleveland Clinic 14
ReXceptor Enters into Licensing Agreement with Case Western Reserve University 15
Vision Medicines Enters into Licensing Agreement with Case Western Reserve University 16
Sujana Biotech Enters into Licensing Agreement with Case Western Reserve University 17
Tracon Pharma Expands Licensing Agreement with Case Western Reserve University 18
NeoProteomics Exercises Option For Licensing Agreement With Case Western Reserve University For Software To Advance Medical Treatments 19
Case Western Reserve University, Key Competitors 20
Case Western Reserve University, Key Employees 21
Case Western Reserve University, Subsidiaries 23

★海外企業調査レポート[Case Western Reserve University-製薬・医療分野：企業M&A・提携分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Sumi-Eagle Corp：企業の戦略的SWOT分析
    Sumi-Eagle Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Renaissance Oil Corp (ROE)：企業の財務・戦略的SWOT分析
    Summary Renaissance Oil Corp (Renaissance Oil), formerly San Antonio Ventures Inc is an oil and gas exploration and development company that acquires and develops high potential shale and mature fields in Mexico. The company utilizes seismic technology and advanced structural interpretation for the …
  • Hayleys PLC (HAYL.N0000)：企業の財務・戦略的SWOT分析
    Summary Hayleys PLC (Hayleys) is a diversified company that offers consumer services. The company’s products include purification products, textiles and construction materials, among others. It offers services such as treasury unit, strategic business development unit, corporate communications, corp …
  • Kartonsan Karton Sanayi ve Ticaret A.S.：企業の戦略・SWOT・財務情報
    Kartonsan Karton Sanayi ve Ticaret A.S. - Strategy, SWOT and Corporate Finance Report Summary Kartonsan Karton Sanayi ve Ticaret A.S. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Actinium Pharmaceuticals Inc (ATNM)：企業の財務・戦略的SWOT分析
    Summary Actinium Pharmaceuticals Inc (ATNM), formerly Cactus Ventures Inc is a biopharmaceutical company that provides development of cancer immunotherapies. The company provides pipeline products such as Iomab-B that is used for hematopoietic stem cells transplantation. It provides Iomab-B through …
  • Topy Industries Ltd：企業の戦略・SWOT・財務情報
    Topy Industries Ltd - Strategy, SWOT and Corporate Finance Report Summary Topy Industries Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Haverty Furniture Companies, Inc. (HVT)：企業の財務・戦略的SWOT分析
    Haverty Furniture Companies, Inc. (HVT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Damas International Ltd：企業の戦略・SWOT・財務分析
    Damas International Ltd - Strategy, SWOT and Corporate Finance Report Summary Damas International Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • China National Materials Co Ltd：企業の戦略・SWOT・財務情報
    China National Materials Co Ltd - Strategy, SWOT and Corporate Finance Report Summary China National Materials Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Corcept Therapeutics Inc (CORT)：企業の財務・戦略的SWOT分析
    Corcept Therapeutics Inc (CORT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Omeros Corp (OMER)：製薬・医療：M&Aディール及び事業提携情報
    Summary Omeros Corp (Omeros) is a biopharmaceutical company that discovers, develops and commercializes small-molecule and protein therapeutics for large-market and orphan indications. The company’s pipeline products include Omidria, a phenylephrine and ketorolac injection for use during cataract su …
  • SR Technics Holding：企業の戦略的SWOT分析
    SR Technics Holding - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Escalon Medical Corp (ESMC)-医療機器分野：企業M&A・提携分析
    Summary Escalon Medical Corp (Escalon) is a medical device company with focus on ophthalmology. It carries out the development and sale of ophthalmic medical devices. Its major products include A-Scan and B-Scan diagnostic tools, UBM high frequency/high resolution ultrasound devices, pachymeters, co …
  • Aleva Neurotherapeutics SA：医療機器：M&Aディール及び事業提携情報
    Summary Aleva Neurotherapeutics SA (Aleva) is a medical device company that provides neuro-stimulation solutions. The company’s products include deep brain stimulation diagnostic systems and deep brain stimulation systems. Its deep brain stimulation systems provide directional stimulation for more p …
  • HitGen LTD：企業のM&A・事業提携・投資動向
    HitGen LTD - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's HitGen LTD Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • Aon Plc：企業の戦略・SWOT・財務分析
    Aon Plc - Strategy, SWOT and Corporate Finance Report Summary Aon Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Banco Cooperativo Espanol S.A.：企業の戦略・SWOT・財務分析
    Banco Cooperativo Espanol S.A. - Strategy, SWOT and Corporate Finance Report Summary Banco Cooperativo Espanol S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Achaogen Inc (AKAO)：製薬・医療：M&Aディール及び事業提携情報
    Summary Achaogen Inc (Achaogen) is a biopharmaceutical company that discovers, develops and commercializes novel anti bacterials for the treatment of multi-drug resistant and gram-negative infections. The company offers plazomicin for the treatment of serious bacterial infections including urinary t …
  • Restaurant Brands New Zealand Limited
    Restaurant Brands New Zealand Limited - Strategy, SWOT and Corporate Finance Report Summary Restaurant Brands New Zealand Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Sumitomo Dainippon Pharma Co., Ltd.：企業の戦略・SWOT・財務分析
    Sumitomo Dainippon Pharma Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Sumitomo Dainippon Pharma Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆